Published in PLoS One on March 18, 2014
The composition of West Nile virus lipid envelope unveils a role of sphingolipid metabolism in flavivirus biogenesis. J Virol (2014) 0.89
Regulation of Flavivirus RNA synthesis and replication. Curr Opin Virol (2014) 0.86
Targeting host lipid synthesis and metabolism to inhibit dengue and hepatitis C viruses. Antiviral Res (2015) 0.84
Recombinant Dengue virus protein NS2B alters membrane permeability in different membrane models. Virol J (2016) 0.82
The many faces of the flavivirus NS5 protein in antagonism of type I interferon signaling. J Virol (2016) 0.78
Lipids and RNA virus replication. Curr Opin Virol (2014) 0.76
Caveolae provide a specialized membrane environment for respiratory syncytial virus assembly. J Cell Sci (2017) 0.75
Composition and three-dimensional architecture of the dengue virus replication and assembly sites. Cell Host Microbe (2009) 4.54
Molecular biology of flaviviruses. Adv Virus Res (2003) 4.39
Lipid rafts, detergent-resistant membranes, and raft targeting signals. Physiology (Bethesda) (2006) 3.08
Dengue virus nonstructural protein 3 redistributes fatty acid synthase to sites of viral replication and increases cellular fatty acid synthesis. Proc Natl Acad Sci U S A (2010) 2.97
Hepatitis C virus RNA replication occurs on a detergent-resistant membrane that cofractionates with caveolin-2. J Virol (2003) 2.86
Recombinant dengue type 1 virus NS5 protein expressed in Escherichia coli exhibits RNA-dependent RNA polymerase activity. Virology (1996) 2.71
Virus entry, assembly, budding, and membrane rafts. Microbiol Mol Biol Rev (2003) 2.68
Pathogens: raft hijackers. Nat Rev Immunol (2003) 2.63
Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: comparison of the BHK suspension test with standard plaque reduction neutralization. J Clin Microbiol (1985) 2.31
Characterization of the hepatitis C virus RNA replication complex associated with lipid rafts. Virology (2004) 2.28
Lipid rafts and membrane traffic. FEBS Lett (2007) 2.25
Cholesterol manipulation by West Nile virus perturbs the cellular immune response. Cell Host Microbe (2007) 2.14
RNA-protein interactions: involvement of NS3, NS5, and 3' noncoding regions of Japanese encephalitis virus genomic RNA. J Virol (1997) 2.12
Wrapping things up about virus RNA replication. Traffic (2005) 2.00
Regulation of caveolin and caveolae by cholesterol in MDCK cells. J Lipid Res (1998) 1.96
Heat shock protein 90 and heat shock protein 70 are components of dengue virus receptor complex in human cells. J Virol (2005) 1.83
Cholesterol biosynthesis modulation regulates dengue viral replication. Virology (2009) 1.64
Architects of assembly: roles of Flaviviridae non-structural proteins in virion morphogenesis. Nat Rev Microbiol (2008) 1.60
The flavivirus NS5 protein is a true RNA guanylyltransferase that catalyzes a two-step reaction to form the RNA cap structure. RNA (2009) 1.58
Glycosylphosphatidyl inositol-anchored proteins and fyn kinase assemble in noncaveolar plasma membrane microdomains defined by reggie-1 and -2. Mol Biol Cell (2001) 1.54
Recombinant dengue virus type 1 NS3 protein exhibits specific viral RNA binding and NTPase activity regulated by the NS5 protein. Virology (1998) 1.46
Crystal structure of a novel conformational state of the flavivirus NS3 protein: implications for polyprotein processing and viral replication. J Virol (2009) 1.29
Lipid rafts in T cell signalling and disease. Semin Cell Dev Biol (2007) 1.29
Chapter 2. New insights into flavivirus nonstructural protein 5. Adv Virus Res (2009) 1.27
Cholesterol effectively blocks entry of flavivirus. J Virol (2008) 1.26
West Nile virus entry requires cholesterol-rich membrane microdomains and is independent of alphavbeta3 integrin. J Virol (2008) 1.19
HIV entry in macrophages is dependent on intact lipid rafts. Virology (2009) 1.15
Identification of the HIV-1 gp41 core-binding motif in the scaffolding domain of caveolin-1. J Biol Chem (2006) 1.09
Role of lipids in virus replication. Cold Spring Harb Perspect Biol (2011) 1.08
Molecular aspects of Dengue virus replication. Future Microbiol (2008) 1.03
Activation of the innate immune response against DENV in normal non-transformed human fibroblasts. PLoS Negl Trop Dis (2011) 0.92
A role for caveolin 1 in assembly and budding of the paramyxovirus parainfluenza virus 5. J Virol (2010) 0.90
Caveolin 1 inhibits HIV replication by transcriptional repression mediated through NF-κB. J Virol (2011) 0.87
Recent developments in understanding dengue virus replication. Adv Virus Res (2010) 0.87
Rafts, anchors and viruses--a role for glycosylphosphatidylinositol anchored proteins in the modification of enveloped viruses and viral vectors. Virology (2008) 0.86
A clinical isolate of dengue virus and its proteins induce apoptosis in HMEC-1 cells: a possible implication in pathogenesis. Arch Virol (2009) 0.85
Antibody-dependent enhancement of dengue virus infection in U937 cells requires cholesterol-rich membrane microdomains. J Gen Virol (2009) 0.85
HIV infection upregulates caveolin 1 expression to restrict virus production. J Virol (2010) 0.84
Monoclonal antibodies against dengue NS2B and NS3 proteins for the study of protein interactions in the flaviviral replication complex. J Virol Methods (2011) 0.84
Cold co-extraction of hemagglutinin and matrix M1 protein from influenza virus A by a combination of non-ionic detergents allows for visualization of the raft-like nature of the virus envelope. Arch Virol (2008) 0.83
Caveolin-1 suppresses human immunodeficiency virus-1 replication by inhibiting acetylation of NF-κB. Virology (2012) 0.83
Lipid rafts, caveolae and GPI-linked proteins. Adv Exp Med Biol (2012) 0.82
Production and characterization of a monoclonal antibody specific for NS3 protease and the ATPase region of Dengue-2 virus. Hybridoma (Larchmt) (2005) 0.81
West Nile Virus (WNV) protease and membrane interactions revealed by NMR spectroscopy. Biochem Biophys Res Commun (2012) 0.80
Generation and characterization of a rat monoclonal antibody against the RNA polymerase protein from Dengue Virus-2. Immunol Invest (2013) 0.76